Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H16NO2 |
Molecular Weight | 146.2074 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CC(=O)OCC[N+](C)(C)C
InChI
InChIKey=OIPILFWXSMYKGL-UHFFFAOYSA-N
InChI=1S/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+1
Molecular Formula | C7H16NO2 |
Molecular Weight | 146.2074 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Acetylcholine is the neurotransmitter at neuromuscular junctions, at synapses in the ganglia of the visceral motor system, and at a variety of sites within the central nervous system. Whereas a great deal is known about the function of cholinergic transmission at the neuromuscular junction and at ganglionic synapses, the actions of acetylcholine in the central nervous system are not as well understood. Cholinergic system is an important system and a branch of the autonomic nervous system which plays an important role in memory, digestion, control of heart beat, blood pressure, movement and many other functions. Acetylcholine in the brain alters neuronal excitability, influences synaptic transmission, induces synaptic plasticity, and coordinates firing of groups of neurons. Miochol®-E (acetylcholine chloride intraocular solution) is used to obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28503857 |
|||
Target ID: CHEMBL2094109 |
|||
Target ID: CHEMBL2362997 |
|||
Target ID: CHEMBL2221346 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | MIOCHOL-E Approved UseTo obtain miosis of the iris in seconds after delivery of the lens in cataract surgery, in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required Launch Date7.48656E11 |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Sources: https://pubmed.ncbi.nlm.nih.gov/11160873/ Page: 6.0 |
yes |
Drug as victim
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Page: 1.0 |
major | |||
Sources: https://pubmed.ncbi.nlm.nih.gov/22206629/ Page: 1.0 |
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: essential role of GM-CSF. | 1999 Nov |
|
Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. | 1999 Sep |
|
Nitric oxide-compromised hypertension: facts and enigmas. | 2000 |
|
Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. | 2000 Mar 7 |
|
Influence of nitric oxide donors and of the alpha(2)-agonist UK-14,304 on acetylcholine release in the pig gastric fundus. | 2001 |
|
Conversion of the ion selectivity of the 5-HT(3a) receptor from cationic to anionic reveals a conserved feature of the ligand-gated ion channel superfamily. | 2001 Apr 6 |
|
Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. | 2001 Feb 1 |
|
Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs. | 2001 Feb 1 |
|
Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex. | 2001 Feb 16 |
|
Inhibition of a Gi-activated potassium channel (GIRK1/4) by the Gq-coupled m1 muscarinic acetylcholine receptor. | 2001 Feb 23 |
|
A pharmacological examination of venoms from three species of death adder (Acanthophis antarcticus, Acanthophis praelongus and Acanthophis pyrrhus). | 2001 Feb-Mar |
|
Rapid eye movement sleep deprivation induces an increase in acetylcholinesterase activity in discrete rat brain regions. | 2001 Jan |
|
Association study of a nicotinic receptor variant with schizophrenic disorders. | 2001 Jan |
|
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. | 2001 Jan |
|
Impaired renal vascular endothelial function in vitro in experimental hypercholesterolemia. | 2001 Jan |
|
Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. | 2001 Jan |
|
Cortical acetylcholine release elicited by stimulation of histamine H1 receptors in the nucleus basalis magnocellularis: a dual-probe microdialysis study in the freely moving rat. | 2001 Jan |
|
Extracellular cyclic ADP-ribose potentiates ACh-induced contraction in bovine tracheal smooth muscle. | 2001 Jan |
|
Adrenal tyrosine hydroxylase activity and gene expression are increased by intraventricular administration of nicotine. | 2001 Jan |
|
Myocardial stunning in exercise-induced ischemia in dogs: lack of late preconditioning. | 2001 Jan |
|
Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. | 2001 Jan |
|
Vasoactive intestinal peptide: cardiovascular effects. | 2001 Jan |
|
Role of calcium and calmodulin in ciliary stimulation induced by acetylcholine. | 2001 Jan |
|
The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. | 2001 Jan |
|
Tetanus and botulinum neurotoxins: turning bad guys into good by research. | 2001 Jan |
|
Twenty years of dendrotoxins. | 2001 Jan |
|
Modulation of choline acetyltransferase synthesis by okadaic acid, a phosphatase inhibitor, and KN-62, a CaM kinase inhibitor, in NS-20Y neuroblastoma. | 2001 Jan |
|
Post-ictal analgesia: involvement of opioid, serotoninergic and cholinergic mechanisms. | 2001 Jan 12 |
|
Changes in sensitivity of cholinoceptors and adrenoceptors during transhemispheric cortical reorganisation in rat SmI. | 2001 Jan 12 |
|
Exercise training in coronary artery disease and coronary vasomotion. | 2001 Jan 2 |
|
The M3 muscarinic acetylcholine receptor expressed in HEK-293 cells signals to phospholipase D via G12 but not Gq-type G proteins: regulators of G proteins as tools to dissect pertussis toxin-resistant G proteins in receptor-effector coupling. | 2001 Jan 26 |
|
exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine. | 2001 Jan 4 |
|
Antagonist of nicotinic acetylcholine receptors (nAChR) enhances formalin-induced nociception in rats: tonic role of nAChRs in the control of pain following injury. | 2001 Jan 5 |
|
Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. | 2001 Jan-Feb |
|
Functional reconstitution and characterization of recombinant human alpha 1-glycine receptors. | 2001 Jun 15 |
|
The role of nitric oxide on the relaxations of rabbit corpus cavernosum induced by Androctonus australis and Buthotus judaicus scorpion venoms. | 2001 May |
Patents
Sample Use Guides
Miochol®-E (acetylcholine chloride intraocular solution) is instilled into the anterior chamber before or after securing one or more sutures. Instillation should be gentle and parallel to the iris face and tangential to pupil border. If there are no mechanical hindrances, the pupil starts to constrict in seconds and the peripheral iris is drawn away from the angle of the anterior chamber. Any anatomical hindrance to miosis must be released to permit the desired effect of the drug. In most cases, 0.5 to 2 mL produces satisfactory miosis. Note that the syringe filter supplied with Miochol-E has a priming volume of 0.6 mL (approximately). In cataract surgery, use Miochol-E only after delivery of the lens. Aqueous solutions of acetylcholine chloride are unstable. Prepare solution immediately before use. Do not use solution which is not clear and colorless. Discard any solution that has not been used.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26049030
Keratocytes were treated with various concentrations of acetylcholine (0.01-1 uM) for 24 h. Acetylcholine enhances keratocyte proliferation through activation of muscarinic acetylcholine receptors.
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Jul 05 23:08:34 UTC 2023
by
admin
on
Wed Jul 05 23:08:34 UTC 2023
|
Record UNII |
N9YNS0M02X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
1707-9
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
||
|
DSLD |
3695 (Number of products:2)
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
||
|
WHO-ATC |
S01EB09
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
||
|
NCI_THESAURUS |
C47796
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
||
|
NDF-RT |
N0000175884
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
||
|
NDF-RT |
N0000175369
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
||
|
WHO-VATC |
QS01EB09
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
65
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
SUB00261MIG
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
Acetylcholine
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
187
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
DB03128
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
D000109
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
C77840
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
N9YNS0M02X
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
100000078828
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
15355
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
ACETYLCHOLINE
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
194
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
200-128-9
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
N9YNS0M02X
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
DTXSID8075334
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY | |||
|
51-84-3
Created by
admin on Wed Jul 05 23:08:34 UTC 2023 , Edited by admin on Wed Jul 05 23:08:34 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> AGONIST |
ACETYLCHOLINE (ACH) IS AN ORGANIC CHEMICAL THAT FUNCTIONS IN THE BRAIN AND BODY OF MANY TYPES OF ANIMALS, INCLUDING HUMANS, AS A NEUROTRANSMITTERA CHEMICAL MESSAGE RELEASED BY NERVE CELLS TO SEND SIGNALS TO OTHER CELLS (NEURONS, MUSCLE CELLS, AND GLAND CELLS).
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |